Pembrolizumab and External Beam Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions
- Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Recurrent Aggressive Non-Hodgkin Lymphoma
- Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma
- Recurrent Non-Hodgkin Lymphoma
- Recurrent T-Cell Non-Hodgkin Lymphoma
- Recurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
- Refractory Aggressive Non-Hodgkin Lymphoma
- Refractory Non-Hodgkin Lymphoma
- Refractory T-Cell Non-Hodgkin Lymphoma
- Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
- Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
- RADIATION: External Beam Radiation Therapy
- BIOLOGICAL: Pembrolizumab
Sponsor
M.D. Anderson Cancer Center
Collaborators